Market Research Logo

Nanotechnology in Medical Applications: The Global Market

Nanotechnology in Medical Applications: The Global Market

Global nanomedicine market was valued at $214.2 billion in 2013 and $248.3 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 16.3% from 2014 through 2019 and reach $528 billion by 2019.

This report provides:

An overview of the global markets for nanotechnology used in medical applications.

Analyses of global market trends, with data from 2012 to 2014, and projections of CAGRs through 2019.

A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications.

Information on a number of significant products in which the nano dimension has made a significant contribution to product effectiveness.

A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine.

Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.

Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.


SCOPE OF REPORT

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and as analyzed by selected national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry is discussed with profiles of the leading companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

CHAPTER 1 Introduction
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
MARKET ANALYSES AND FORECASTS
METHODOLOGY
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
DEFINITION OF NANOMEDICINE
RESEARCH AND COMMERCIALIZATION
APPLICATIONS
DRUG DELIVERY
DRUGS AND THERAPY
IN VIVO IMAGING
IN VITRO DIAGNOSTICS
BIOMATERIALS
ACTIVE IMPLANTS
MARKET
SUMMARY TABLE GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, THROUGH 2019 ($ BILLIONS)
SUMMARY FIGURE GLOBAL NANOMEDICINE MARKET BY THERAPEUTIC AREA, 2012-2019 ($ BILLIONS)
CHAPTER 3 OVERVIEW
ABOUT NANOTECHNOLOGY
THE MANY USES OF NANOTECHNOLOGY
MEDICAL APPLICATIONS
ENVIRONMENTAL APPLICATIONS
MILITARY APPLICATIONS
COSMETICS
APPLICATIONS IN DEVELOPMENT
THE TOOLS OF NANOTECHNOLOGY
C60/FULLERENES
CARBON NANOTUBES
NANOPARTICLES
NANOWIRES
MOLECULAR NANOTECHNOLOGY
RISKS OF NANOTECHNOLOGY
POISON/TOXICITY
NANOTECHNOLOGY IN THE MARKETPLACE
MEDICAL NANOTECHNOLOGY - NANOMEDICINE
FUTURE POSSIBILITIES
MARKET POTENTIAL
CHAPTER 4 NANOMEDICINE
DEVELOPMENT OF NANOMEDICAL TECHNOLOGIES
TABLE 1 NANOMEDICINE – ESTMIATED TIMESCALE BY DECADE
TABLE 2 MAIN NANOTECHNOLOGIES AND APPLICATIONS IN MEDICINE
LIPOSOMES
TABLE 3 MARKETED LIPOSOMAL NANOPHARMACEUTICAL PRODUCTS
DENDRIMERS
NANOCRYSTALS
TABLE 4 MARKETED NANOCRYSTAL PHARMACEUTICAL PRODUCTS
MICELLES
TABLE 5 MARKETED PRODUCTS IN MICELLE FORM
FULLERENES
POLYMERIC NANOPARTICLES
NANOPARTICLE-DRUG CONJUGATES
LIGAND-TARGETED NANOPARTICLES
CERAMIC NANOPARTICLES
VIROSOME NANOPARTICLES
CHAPTER 5 THERAPEUTIC USES OF NANOMEDICINE
CANCER DIAGNOSTICS AND THERAPY
SILICA NANOSPHERES
NANOSCALE HYDROGEL SHELLS
Carbon Nanoparticles
Photodynamic Therapy and Gold
Dendrimer Conjugates
Ligand-Targeted Emulsion Technologies
Linear Cyclodextrin-Containing Polymers
Smart Lipid-Based Nanocarriers
Thermotherapy Using Magnetic Nanoparticles
Targeted Cell Destruction
Nanoshells
DRUG DELIVERY
TABLE 6 MARKETED PRODUCTS WITH NANO-ENHANCED DRUG DELIVERY
AlphaRx
Aphios
Bind Biosciences
Biodelivery Sciences
Calando Pharmaceuticals Inc.
Capsulution NanoScience
Ceramisphere
CytImmune
Health Plus International
IGI Laboratories Inc.
Labopharm
MagnaMedics
Mebiopharm
Nanocopoeia
NanoCrystal
NanoMed
NanoCyte
NanoPharm
Nanotherapeutics
Nanotrope
pSivida
Selecta Biosciences
SoluBest
Transave/Insmed
INFECTION CONTROL
Silver Nanoparticles against Infection
Detecting Nanobacteria
Killing Viruses
CHAPTER 6 DIAGNOSTIC TOOLS
PRACTICAL APPLICATION OF TOOLS
COMPANIES THAT DEVELOP THE TOOLS
BioCrystal/InVitrogen
BioForce
Biophage
CombiMatrix
Farfield Sensors
GE Healthcare BioSciences
Immunicon
MagnaMedics
Nanogen
Nanosphere
Qiagen
Sphere
TransGenex
Veredus
VARIOUS THERAPEUTIC TARGETS TECHNOLOGIES
Anthrax
Cholesterol
Artificial Retina
Nerve Regeneration
Crossing the Blood-Brain Barrier
Protecting Against Radiation Damage
Antibody Therapeutics
Hemostasis
Bone Fracture Repair
Dental Implant and Tissue Regeneration
Vaccine Adjuvant
Treatment of Thrombosis
Coatings for Stents and Other Devices
CHAPTER 7 FUTURE TRENDS AND RESEARCH POSSIBILITIES
NON-INVASIVE NANODEVICES
EXTRACELLULAR DEVICES
INTRACELLULAR DEVICES
NANOMACHINES TO CONTROL TISSUE HEALING
ELIMINATING VIRUSES
CORRECTING CHEMISTRY
NEW ORGANS AND LIMBS
FUNDAMENTAL NANOTECHNOLOGY RESEARCH
UNITED STATES
University at Albany-SUNY
Cornell University
University of Michigan
Rice University
University of Pennsylvania
University of Virginia
University of North Carolina
Ohio State University
Northwestern University
University of Pittsburgh
Case Western Reserve University
University of California at Berkeley
EUROPE
TABLE 7 EUROPEAN NANOCENTRES
JAPAN
Development of Active Targeting DDS
Development of Novel Tissue Engineering
Development of New Biomaterials
THE RISK FACTOR
CHAPTER 8 MARKETS FOR NANOMEDICINE
TABLE 8 MARKETED NANOPHARMACEUTICALS
TABLE 9 MARKETED NANO-IMAGING, DIAGNOSTICS AND BIOMATERIALS
MARKET DRIVERS
MARKET ESTIMATES AND FORECASTS
TABLE 10 GLOBAL MARKET SHARE FOR NANOTECHNOLOGY BY INDUSTRY SECTOR, 2010 (%)
GLOBAL NANOMEDICINE MARKET
TABLE 11 GLOBAL NANOMEDICINE, NANOPHARMACEUTICAL AND NANODIAGNOSTIC MARKET, THROUGH 2019 ($ BILLIONS/%)
MAIN PRODUCT CATEGORIES
DRUG DELIVERY
MOLECULAR DIAGNOSTICS
MARKET ANALYSIS BY CLINICAL APPLICATION
Cancer
TABLE 12 MAJOR MARKETED ANTICANCER NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALES ($ MILLIONS)
TABLE 13 GLOBAL MARKET FOR CANCER NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
CNS Disorders
TABLE 14 MAJOR MARKETED CNS NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFATURER AND SALES ($ MILLIONS)
TABLE 15 GLOBAL MARKET FOR CNS NANOMEDICINES
Infection
TABLE 16 MAJOR MARKETED ANTI-INFECTIVE NANOPHARMACEUTICAL PRODUCTS BY COMPONENT, MANUFACTURER AND SALE ($ MILLIONS)
TABLE 17 GLOBAL MARKET FOR ANTI-INFECTIVE NANOMEDICINE, NANOTHERAPEUTICS AND NANODIAGNOSTICS ($ BILLIONS)
Cardiovascular and Autoimmune Disorders
TABLE 18 MAJOR MARKETED NANOMEDICINE PRODUCTS FOR CARDIOVASCULAR AND INFLAMMATORY DISEASES BY COMPONENT, MANUFACTURER AND SALE ($ BILLIONS)
TABLE 19 GLOBAL MARKET FOR CARDIOVASCULAR AND ANTI-INFLAMMATORY NANOPRODUCTS ($ BILLIONS)
REGIONAL MARKET ANALYSIS
U.S.
TABLE 20 U.S. NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
Japan
TABLE 21 JAPANESE NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
Europe
TABLE 22 GERMAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
TABLE 23 FRENCH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
TABLE 24 UNITED KINGDOM NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
TABLE 25 ITALIAN NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
TABLE 26 BELGIUM AND NETHERLANDS NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
TABLE 27 SPANISH NANOMEDICINE MARKET, THROUGH 2019 ($ BILLIONS/%)
CHAPTER 9 COMPANY PROFILES
COMPANIES THAT COMPRISE THE GLOBALNANOMEDICINE INDUSTRY
ABLYNX NV
ABRAXIS BIOSCIENCE INC.
ACRYMED INC.
ACUSPHERE INC.
AMAG PHARMACEUTICALS INC.
ALLTRACELL
ANSON NANO-BIOTECHNOLOGY
APHIOS CORP.
Protein Nanoparticles
Polymer Nanospheres
Phospholipid Nanosomes
BIND THERAPEUTICS INC.
BIOCRYSTAL LTD.
BIOFORCE NANOSCIENCES INC.
The ViriChip Virus Detection Platform
BIO-GATE AG
Medical Applications
BIOPHAGE PHARMA INC.
BioPhage Products
Development through Collaborations:
Phages
BIOPHAN TECHNOLOGIES INC.
CALANDO PHARMACEUTICALS INC.
About CALAA-01
C SIXTY INC.
COMBIMATRIX CORP.
Drug Development
ELAN DRUG TECHNOLOGIES
FARFIELD SCIENTIFIC
GE HEALTHCARE
IGI LABORATORIES INC.
KEREOS INC.
KER-1001
KER-1002
KER-1003
KEYSTONE NANO INC.
NanoJackets
KLEINDIEK NANOTECHNIK GMBH
NanoWorkstation
LABOPHARM INC.
LIPLASOME PHARMA A/S
LUMERA CORP.
Product Portfolio
Nanocapture Microarrays
MAGFORCE NANOTECHNOLOGIES AG
MAGNAMEDICS GMBH
Diagnostics:
Efficient and Low-Cost Diagnostics
Multifunctional Drug Carrier
MICROFLUIDICS INTERNATIONAL CORP.
MIDATECH PHARMA PLC
MIV THERAPEUTICS INC.
Cardiovascular Heart Stents
MOLECULAR PROFILES (NOW JUNIPER PHARMACEUTICALS )
NANOBAC PHARMACEUTICALS INC.
NANOBIO CORP.
NANOBIOTIX
NANOCARRIER CO. LTD.
NANOCOPOEIA INC.
NANOCYTE INC.
NANOGEN INC.
Electronic Microarray
Instrumentation
Molecular Biology Workstation
Molecular Biology Workstation Cartridge
NanoChip 400 System
NANOLOGIX INC.
NANOMED PHARMACEUTICALS INC.
NANOMIX INC.
NANOSPECTRA BIOSCIENCES INC.
NANOSPHERE INC.
NANOSTRUCTURES INC.
NANOSYN INC.
NANOTHERAPEUTICS INC.
NANOTROPE INC.
Technology
NANOVIRICIDES INC.
Pipeline
NUCRYST PHARMACEUTICALS
NUTRALEASE LTD.
ORION INTEGRATED BIOSCIENCES INC.
Genomic Signatures
Rational Antiviral Development
Discovery of Malaria Invasion Pathways
ORTHOVITA INC.
PIONEER SURGICAL TECHNOLOGY
PSIVIDA LTD.
QIAGEN NV
SOLUBEST LTD.
STARPHARMA
Dendrimer Nanotechnology
TECAN GROUP LTD.
TRANSGENEX NANOBIOTECH INC.
Therapy
CHAPTER 10 APPENDIX
GLOSSARY

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report